Legal Representation
Attorney
Lawrence E Abelman
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 8, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 15, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 21, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 1, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 15, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 16, 2002 | I | PAPER RECEIVED | Loading... | |
| Sep 13, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 13, 2002 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Oct 15, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 23, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Apr 21, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 4, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 30, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
Diagnostic reagents and therapeutic reagents in the nature of human monoclonal antibodies for scientific and research use in the field of human therapeutics
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Diagnostic and therapeutic reagents in the nature of human monoclonal antibodies for clinical medical laboratory use; medical diagnostic and therapeutic regents in the nature of human monoclonal antibodies for use in the treatment of cancer targeting, chronic inflammation, pathogenic infections, vaccination in the field of human therapeutics
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Laboratory research in the field of the isolation and purification of human monoclonal antibodies; laboratory research in the field of human monoclonal antibodies, namely research regarding the isolation and purification of human monoclonal antibodies; biological research and testing in the field of the isolation and purification of human monoclonal antibodies; scientific research; medical services and biochemical research regarding the production of human proteins in human cell lines and the importance of human post-translational modifications; chemical and medical research, synthesis and development of human monoclonal antibodies for others; biochemical research; laboratories and analysis for others
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
PER CMAB
Classification
International Classes
001
005
042